Quarterly ResultNov 4, 2026, 04:46 PM
LeMaitre Vascular Q3 Sales Up 11% to $68M; Acquires B. Braun Assets
AI Summary
LeMaitre Vascular, Inc. reported strong preliminary financial and operational results for the third quarter of 2026. Sales increased by 11% year-over-year to $68.0 million, with organic growth of 12%. Diluted EPS was $0.65, up 5% year-over-year on an adjusted basis. The company also announced a quarterly dividend of $0.25 per share and provided guidance for Q4 and the full year 2026. Additionally, LeMaitre completed the acquisition of certain vascular assets from B. Braun for $19.2 million in October 2026.
Key Highlights
- LeMaitre Vascular reported Q3 2026 sales of $68.0mm, an 11% increase year-over-year (12% organic).
- Q3 2026 diluted EPS was $0.65, a 5% increase year-over-year on an adjusted basis.
- The company announced a quarterly dividend of $0.25 per share, payable on December 3, 2026.
- In October 2026, LeMaitre acquired certain vascular assets from B. Braun for $19.2mm.
- Provided Q4 2026 guidance: Sales $69.9mm - $71.9mm, EPS $0.70 - $0.75.
- Provided Full Year 2026 guidance: Sales $274.8mm - $276.8mm, EPS $2.77 - $2.82.
- Cash increased $13.5mm sequentially to $390mm at September 30, 2026.
Price Impact
More from LMAT